Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreasing Function01:27

Decreasing Function

246
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
246
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

627
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
627
Transgenic Organisms00:53

Transgenic Organisms

33.2K
Overview
33.2K
Decreased Body Temperature01:29

Decreased Body Temperature

1.0K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.0K
Decreased pulse rate01:14

Decreased pulse rate

864
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
864
Internal Receptors01:31

Internal Receptors

74.4K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imipramine Can Block Human Cardiac H1-Histamine Receptors.

Journal of cardiovascular pharmacology·2026
Same author

Mechanisms of systolic heart failure in PP2CxPP5 double transgenic mice.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Contractile effects of dulaglutide in the human atrium.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Protein phosphatase 2A impairs cardiac uptake of glucose in the mammalian heart.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Acute Contractile Effects of Glucagon-like-Peptide-1 Receptor Agonists in the Human Heart.

Pharmaceutics·2026
Same author

Positive inotropic and chronotropic effects of amisulpride via stimulation of 5-HT<sub>4</sub> serotonin receptors in the isolated atrium from mouse and humans.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Related Experiment Video

Updated: Jan 25, 2026

Imaging Neural Activity in the Primary Somatosensory Cortex Using Thy1-GCaMP6s Transgenic Mice
07:04

Imaging Neural Activity in the Primary Somatosensory Cortex Using Thy1-GCaMP6s Transgenic Mice

Published on: January 7, 2019

11.7K

Which phosphodiesterase can decrease cardiac effects of 5-HT4 receptor activation in transgenic mice?

Joachim Neumann1, Benedikt Käufler1, Ulrich Gergs2

  • 1Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, 06097, Halle, Germany.

Naunyn-Schmiedeberg'S Archives of Pharmacology
|April 25, 2019
PubMed
Summary
This summary is machine-generated.

Serotonin (5-HT) increases heart contraction and rate in specific mice via cAMP. Phosphodiesterase 4 (PDE4) activity diminishes this inotropic effect, while PDE2 and PDE4 influence contraction but not heart rate.

Keywords:
5-HT4 receptorChronotropyInotropyPhosphodiesteraseSerotoninTransgenic mice

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

2.1K

Related Experiment Videos

Last Updated: Jan 25, 2026

Imaging Neural Activity in the Primary Somatosensory Cortex Using Thy1-GCaMP6s Transgenic Mice
07:04

Imaging Neural Activity in the Primary Somatosensory Cortex Using Thy1-GCaMP6s Transgenic Mice

Published on: January 7, 2019

11.7K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

2.1K

Area of Science:

  • Cardiology
  • Pharmacology
  • Molecular Biology

Background:

  • Serotonin (5-hydroxy-tryptamine, 5-HT) elicits concentration-dependent positive inotropic and chronotropic effects in transgenic (TG) mice overexpressing the human 5-HT4a receptor.
  • These effects are primarily mediated by cyclic adenosine 3',5'-monophosphate (cAMP) within TG cardiomyocytes.

Purpose of the Study:

  • To investigate the role of endogenous phosphodiesterases (PDEs) in antagonizing the cardiac effects of serotonin (5-HT).
  • To determine the specific PDE subtypes (PDE2, PDE3, PDE4) involved in modulating 5-HT-induced inotropic and chronotropic responses in TG mice.

Main Methods:

  • Administered selective PDE inhibitors (EHNA for PDE2, cilostamide for PDE3, rolipram for PDE4) and an unspecific inhibitor (IBMX) to TG mice.
  • Assessed the inotropic (force of contraction) and chronotropic (beating rate) effects of 5-HT in the presence of various PDE inhibitors and their combinations.
  • Compared responses in TG mice with their wild-type (WT) littermates.

Main Results:

  • PDE4 and PDE2 inhibitors (rolipram, EHNA) in combination with PDE3 inhibitors (cilostamide) or alone potentiated 5-HT's inotropic effects, indicating PDE4 and PDE2 regulate contraction.
  • Specific PDE inhibitors did not alter the potency of 5-HT to increase heart rate, suggesting chronotropic effects are independent of PDE activity.
  • Endogenous PDE4 activity was found to diminish the positive inotropic effect of 5-HT and basal cardiac force in TG mice.

Conclusions:

  • The positive chronotropic effect of 5-HT in TG mice does not involve PDE activities.
  • The positive inotropic effect of 5-HT and basal cardiac force in TG mice are attenuated by endogenous PDE4 activity.
  • Phosphorylation of PDE4 may enhance its activity when PDE2 or PDE3 are inhibited, further impacting cardiac contractility.